| # | Drug | Count |
|---|---|---|
| 0 | IBUPROFEN | 29 |
| 1 | EXENATIDE | 20 |
| 2 | LEVOTHYROXINE SODIUM | 20 |
| 3 | ASPIRIN | 18 |
| 4 | ASPIRIN 325 MG | 18 |
| 5 | ASPIRIN 81 MG | 18 |
| 6 | DIPHENHYDRAMINE HYDROCHLORIDE | 16 |
| 7 | IBUPFROFEN | 15 |
| 8 | IBUPROFEN 200 MG | 15 |
| 9 | IBUPROFEN 200MG | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIDOCAINE HCL 3% | 2 | 0.0044 |
| 1 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 3 | 0.0031 |
| 2 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 3 | 0.0016 |
| 3 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 6 | 0.0013 |
| 5 | AMIFOSTINE | 1 | 0.0012 |
| 6 | AGALSIDASE BETA | 10 | 0.0011 |
| 7 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 2 | 0.0009 |
| 8 | MEFENAMIC ACID | 2 | 0.0009 |
| 9 | REMIFENTANIL HYDROCHLORIDE | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 72 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 22 |
| 2 | GLP-1 Receptor Agonist [EPC] | 20 |
| 3 | Benzodiazepine [EPC] | 19 |
| 4 | Proton Pump Inhibitor [EPC] | 19 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 18 |
| 6 | Central Nervous System Stimulant [EPC] | 16 |
| 7 | Corticosteroid [EPC] | 15 |
| 8 | Insulin Analog [EPC] | 14 |
| 9 | Vitamin C [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Skin Test Antigen [EPC] | 3 | 0.0016 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 10 | 0.0010 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 5 | Photoenhancer [EPC] | 1 | 0.0003 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Antiparasitic [EPC] | 1 | 0.0002 |
| 9 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |